Summit Global Investments - TREACE MED CONCEPTS INC ownership

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 79 filers reported holding TREACE MED CONCEPTS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Summit Global Investments ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q3 2021$285,00010,6000.02%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q4 2021
NameSharesValueWeighting ↓
NEXT CENTURY GROWTH INVESTORS LLC 1,575,369$34,768,0004.24%
EMERALD ADVISERS, LLC 1,120,765$24,735,0001.28%
EMERALD MUTUAL FUND ADVISERS TRUST 911,509$20,117,0001.27%
SECTORAL ASSET MANAGEMENT INC 243,674$5,378,0001.06%
Perceptive Advisors 1,601,979$35,356,0001.03%
Novo Holdings A/S 588,308$12,984,0000.62%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 485,086$10,706,0000.55%
ESSEX INVESTMENT MANAGEMENT CO LLC 142,954$3,155,0000.50%
G2 Investment Partners Management LLC 55,000$1,214,0000.38%
TimesSquare Capital Management, LLC 1,014,500$22,390,0000.31%
View complete list of TREACE MED CONCEPTS INC shareholders